Role of radiation therapy in gastric adenocarcinoma.

摘要: Outcomes in patients with gastric cancer the United States remain disappointing, a five-year overall survival rate of approximately 23%. Given high rates local-regional control following surgery, strong rationale exists for use adjuvant radiation therapy. Randomized trials have shown superior local radiotherapy and improved chemoradiation. The benefit chemoradiation who undergone D2 lymph node dissection by an experienced surgeon is not known, therapy addition to chemotherapy continues be defined. In unresectable disease, allows long-term small number provides effective palliation. Most show combined modality compared or alone. The pre-operative, intra-operative, 3D conformal, intensity modulated promising but requires further study. The current article reviews role treatment resectable carcinoma, focusing on recommendations States.